Intravenous epinephrine infusion test in diagnosis of catecholaminergic polymorphic ventricular tachycardia

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 2, 2012, Pages 194-199

  Marjamaa, Annukka ^a   Hiippala, Anita ^b   Arrhenius, Bianca ^a   Lahtinen, Annukka M ^a   Kontula, Kimmo ^a   Toivonen, Lauri ^a   Happonen, Juha Matti ^b   Swan, Heikki ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

catecholaminergic polymorphic ventricular tachycardia; epinephrine; exercise stress test; premature ventricular complex; RYR2; ventricular tachycardia

Indexed keywords

ADRENALIN; RYANODINE RECEPTOR 2;

ADULT; ARTICLE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EXERCISE; EXERCISE TEST; FEMALE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; EPINEPHRINE; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TACHYCARDIA, VENTRICULAR; YOUNG ADULT;

EID: 84857032672     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02188.x     Document Type: Article

References (24)

1. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P,: Catecholaminergic polymorphic ventricular tachycardia in children: A 7-year follow-up of 21 patients. Circulation 1995; 91: 1512-1519.
2. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, Donarum EA, Marino M, Tiso N, Viitasalo M, Toivonen L, Stephan DA, Kontula K,: Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001; 103: 485-490. (Pubitemid 32116230)
3. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA,: Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196-200. (Pubitemid 32095402)
4. Lehnart SE, Wehrens XH, Laitinen PJ, Reiken SR, Deng SX, Cheng Z, Landry DW, Kontula K, Swan H, Marks AR,: Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 2004; 109: 3208-3214.
5. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL,: ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e385-e484.
6. Brugada P, Brugada J,: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-1396.
7. Noda T, Takaki H, Kurita T, Suyama K, Nagaya N, Taguchi A, Aihara N, Kamakura S, Sunagawa K, Nakamura K, Ohe T, Horie M, Napolitano C, Towbin JA, Priori SG, Shimizu W,: Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J 2002; 23: 975-983. (Pubitemid 35203877)
8. Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, Aihara N, Sunagawa K, Echigo S, Miyamoto Y, Yoshimasa Y, Nakamura K, Ohe T, Towbin JA, Priori SG, Kamakura S,: Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004; 1: 276-283. (Pubitemid 39549754)
9. Ackerman MJ, Khositseth A, Tester DJ, Hejlik JB, Shen WK, Porter CB,: Epinephrine-induced QT interval prolongation: A gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 2002; 77: 413-421. (Pubitemid 34465148)
10. Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y, Saito A, Kurosaki K, Jouo K, Koujiro M, Konishi S, Matsuoka S, Oono T, Hayakawa S, Miura M, Ushinohama H, Shibata T, Niimura I,: Catecholaminergic polymorphic ventricular tachycardia: Electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003; 89: 66-70. (Pubitemid 36044293)
11. Krahn AD, Gollob M, Yee R, Gula LJ, Skanes AC, Walker BD, Klein GJ,: Diagnosis of unexplained cardiac arrest: Role of adrenaline and procainamide infusion. Circulation 2005; 112: 2228-2234. (Pubitemid 41464564)
12. Krahn AD, Healey JS, Chauhan V, Birnie DH, Simpson CS, Champagne J, Gardner M, Sanatani S, Exner DV, Klein GJ, Yee R, Skanes AC, Gula LJ, Gollob MH,: Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER). Circulation 2009; 120: 278-285.
13. Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, Mannens MM, Wilde AA, Ackerman MJ,: The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: A comprehensive open reading frame mutational analysis. J Am Coll Cardiol 2009; 54: 2065-2074.
14. Bauce B, Rampazzo A, Basso C, Bagattin A, Daliento L, Tiso N, Turrini P, Thiene G, Danieli GA, Nava A,: Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: Early diagnosis of asymptomatic carriers. J Am Coll Cardiol 2002; 40: 341-349. (Pubitemid 34756298)
15. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A,: Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002; 106: 69-74. (Pubitemid 34747444)
16. Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K, Kere J, Keto P, Kontula K, Toivonen L,: Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999; 34: 2035-2042. (Pubitemid 30002662)
17. Kontula K, Laitinen PJ, Lehtonen A, Toivonen L, Viitasalo M, Swan H,: Catecholaminergic polymorphic ventricular tachycardia: Recent mechanistic insights. Cardiovasc Res 2005; 67: 379-387. (Pubitemid 41019547)
18. Magnano AR, Talathoti N, Hallur R, Bloomfield DM, Garan H,: Sympathomimetic infusion and cardiac repolarization: The normative effects of epinephrine and isoproterenol in healthy subjects. J Cardiovasc Electrophysiol 2006; 17: 983-989.
19. Jouven X, Zureik M, Desnos M, Courbon D, Ducimetiere P,: Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med 2000; 343: 826-833.
20. Frolkis JP, Pothier CE, Blackstone EH, Lauer MS,: Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003; 348: 781-790. (Pubitemid 36245754)
21. Morshedi-Meibodi A, Evans JC, Levy D, Larson MG, Vasan RS,: Clinical correlates and prognostic significance of exercise-induced ventricular premature beats in the community: The Framingham Heart Study. Circulation 2004; 109: 2417-2422. (Pubitemid 38679561)
22. Faris JV, McHenry PL, Jordan JW, Morris SN,: Prevalence and reproducibility of exercise-induced ventricular arrhythmias during maximal exercise testing in normal men. Am J Cardiol 1976; 37: 617-622.
23. Saini V, Graboys TB, Towne V, Lown B,: Reproducibility of exercise-induced ventricular arrhythmia in patients undergoing evaluation for malignant ventricular arrhythmia. Am J Cardiol 1989; 63: 697-701. (Pubitemid 19080351)
24. Tester DJ, Kopplin LJ, Will ML, Ackerman MJ,: Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm 2005; 2: 1099-1105. (Pubitemid 41472159)